QualityStocksNewsBreaks – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) Subsidiary MindWave Enters Joint Venture Agreement to Establish Bermuda Insurance Business
Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) announced that its wholly owned subsidiary, MindWave Innovations Inc. USA, has entered into a shareholders and joint venture agreement with Singapore-based Skalup Capital Pte Ltd to establish an insurance and technology business in Bermuda under the working brand Monaco Insurance, subject to regulatory approval. Under the agreement, MindWave will hold 75% of the venture's common equity, while Skalup will hold 25%. The proposed business will combine MindWave's blockchain infrastructure and digital-asset-backed capital through staking with Skalup's underwriting expertise and regulatory support. The venture plans to pursue licensing from the Bermuda Monetary Authority ("BMA"),…